CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease [Phase 3]
Summary
A Phase 3 trial evaluating ALXN1840 versus standard of care in pediatric Wilson disease participants was terminated, and trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Wilson Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-10-15